GE HealthCare Technologies Inc. with ticker code (GEHC) have now 13 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $100.23 and $82.00 calculating the average target share price we see $92.02. (at the time of writing). Now with the previous closing price of $89.41 this would imply there is now a potential upside of 2.9%. The day 50 moving average is $82.51 while the 200 day moving average is $75.06. The market cap for the company is 41.26B. The stock price for the company is currently is currently $90.61 USD
The potential market cap would be $42,464,329,566 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 29.81, revenue per share of $42.97 and a 6.15% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
